EDISON, N.J.--(BUSINESS WIRE)--MTF Biologics, a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients, and advancing science, has announced that Jan Finn, President and Chief Executive Officer of the Midwest Transplant Network, has joined the organization’s Board of Directors.
“MTF Biologics is excited to welcome Jan onto our Board of Directors,” said Joe Yaccarino, President and Chief Executive Officer at MTF. “Jan brings nearly 30 years of organ procurement experience to the MTF Biologics Board. She is extremely passionate about our work to provide high-quality tissue grafts from donated human tissue and understands the positive impact that the gift of donation has on the lives of both recipients and donor families. We know that she will be an invaluable asset to our MTF team.”
As the President/Chief Executive Officer for Midwest Transplant Network (MTN), Ms. Finn is responsible for overseeing the executive leadership of a team that directs all organ and tissue donation operations in Kansas and Western Missouri. Under her leadership, MTN increased its donation rates and recovery of organs and tissues to record levels. MTN ranks in the top quartile nationally among other OPOs.
Ms. Finn currently serves on the Missouri Governor’s Advisory Council on Organ and Tissue Donation, the Legislative and Regulatory Affairs Committee for the Association of Organ Procurement Organizations (AOPO) and as a board member for the Gift of Life Foundation and the National Organ Donation Alliance. She is a past President of the North American Transplant Coordinators Organization (NATCO) and achieved certification from the American Board for Transplant Coordination as a Certified Procurement Transplant Coordinator (CPTC).
Ms. Finn began her career at St. John’s Regional Medical Center in Joplin, MO, working for 13 years as a Registered Nurse primarily in critical care. She holds undergraduate degrees from Missouri Southern State University and Pittsburg State University, as well as Master’s in Science from the University of Kansas. She was a member of the Sigma Theta Tau Nursing Honor Society and was credentialed as a CCRN by the American Association of Critical Care Nurses.
“I am delighted to join my friends at MTF Biologics as a member of their Board of Directors,” said Ms. Finn. “MTF Biologics remains a global leader in tissue and organ transplantation, and I look forward to working with the Board to help further MTF’s legacy of honoring donors and saving and healing lives.”
ABOUT MTF BIOLOGICS
MTF Biologics is a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients and advancing science. They provide unmatched service, resources, and expertise to donors and their loved ones who give the gift of donation, people who depend on tissue and organ transplants, healthcare providers, and clinicians and scientists.
The International Institute for the Advancement of Medicine (IIAM), a Division of MTF Biologics, honors donors of non-transplantable organs by providing their gifts to the medical research community to combat and cure diseases. Statline, also a Division of MTF Biologics, provides specialized communications and technology expertise to organ, tissue, and eye procurement organizations, as well as the hospitals and patients that they serve. Its sister organization, Deutsches Institute for Zell-und Gewebeersatz – DIZG (The German Institute for Cell and Tissue Transplantation) expands its reach to patients across the globe. For more information, visit www.mtfbiologics.org.